Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate to severe UC patients.

Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or ...

UCB’s Bimzelx is firmly on physicians’ radars, with Spherix Global Insights finding that awareness of the drug was tracking ...

Get an expert’s answers to common questions about how physical therapy can help with psoriatic arthritis, and learn how to get started. Living with psoriatic arthritis can mean chronic joint ...

The majority of people with psoriatic arthritis first experience skin symptoms. One of the most common is a rash with thick, discolored skin covered with flaky, lighter-colored patches.

Johnson & Johnson’s Tremfya, which held the same position the previous month. AbbVie’s two immunology mainstays, Rinvoq and Skyrizi, which often took the top two spending spots throughout 2024 ...

Rheumatoid arthritis is an autoimmune disease that is characterized by inflammation of the joints and the subsequent destruction of cartilage and erosion of the bone. Patients with rheumatoid ...

Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis for Skyrizi, and Rheumatoid Arthritis, Psoriatic Arthritis, Atopic Dermatitis, Ulcerative Colitis, Crohn's Disease, Ankylosing ...

The decline was offset by sales of its newer arthritis drugs Skyrizi, which soared by 57% to $3.78 billion, and Rinvoq, which logged a 46% gain to $1.83 billion. Chief Executive Robert Michael ...

Rheumatoid arthritis and osteoarthritis are two of the most common types of arthritis, but they differ in causes, symptoms, and treatment. Understanding the differences is important for proper ...

Psoriatic arthritis (PsA) a type of arthritis affecting joints. PsA may also involve enthesitis, a condition that affects ligaments and tendons where they connect to bone. Psoriatic arthritis (PsA ...